Talat Imran - Mar 21, 2024 Form 4 Insider Report for Rani Therapeutics Holdings, Inc. (RANI)

Role
Chief Executive Officer, Director
Signature
Talat Imran
Stock symbol
RANI
Transactions as of
Mar 21, 2024
Transactions value $
$0
Form type
4
Date filed
3/22/2024, 09:00 PM
Previous filing
Dec 19, 2023
Next filing
Dec 10, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RANI Stock Option (Right to Buy) Award $0 +1.09M $0.00 1.09M Mar 21, 2024 Class A Common Stock 1.09M $3.60 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 21, 2024.